Objective: To observe the clinical effect of Shensong Yangxin capsules for ventricular premature beats of coronary heart disease.Methods:Selected 100 cases of patients with ventricular premature beats of coronary heart disease and divided them into the experiment group and the control group randomly,50 cases in each group.The experiment group received Shensong Yangxin capsules for treatment,while the control group received amiodaron.Both groups received treatmentforfourweeks.Compared the clinical effect,the curative effectofventricularpremature beats and electrocardiogram in both groups before and after treatment.Results:After treatment,the total effective rate of the two therapies was 90.0%in the experiment group and was 78.0%in the control group,difference being significant(P<0.05).The total effective rate of the curative effect of ventricular premature beats was 70.0%in the experiment group and was 50.0%in the control group,difference being significant(P<0.05).The total effective rate of the curative effect of electrocardiogram was 98.0%in the experiment group and was 78.0%in the control group,difference being significant(P<0.05).Conclusion:Shensong Yangxin capsules have exact curative effect in treating patients with ventricular premature beats of coronary heart disease,which is worthy of clinical promotion and application.